Intelligence Platform

Patents

Browse 650 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

patent

US 6562978

Cyclic amine compounds as CCR5 antagonists

Takeda Chemical Industries Ltd. · Granted Tue May 13 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 08 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6551989

Preventing airway mucus production by administration of EGF-R antagonists

The Regents of the University of California · Granted Tue Apr 22 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 17 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6541469

CRF receptor antagonists and methods relating thereto

Neurocrine Biosciences, Inc. · Granted Tue Apr 01 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 27 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6537998

Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

Neurocrine Biosciences, Inc. · Granted Tue Mar 25 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 20 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6531475

CRF receptor antagonists and methods relating thereto

Neurocrine Biosciences, Inc. · Granted Tue Mar 11 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 06 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6525062

Method of treating pain using nalbuphine and opioid antagonists

The Regents of the University of California · Granted Tue Feb 25 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 20 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6514982

CRF receptor antagonists and methods relating thereto

Neurocrine Biosciences, Inc. · Granted Tue Feb 04 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 30 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6511811

Protein kinase C antagonist related to insulin receptor

The Regents of the University of California · Granted Tue Jan 28 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 23 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6500839

CRF receptor antagonists and methods relating thereto

Neurocrine Biosciences, Inc. · Granted Tue Dec 31 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 26 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6472179

Receptor based antagonists and methods of making and using

REGENERON PHARMACEUTICALS, INC. · Granted Tue Oct 29 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 24 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6440960

CRF receptor antagonists and methods relating thereto

Neurocrine Biosciences, Inc. · Granted Tue Aug 27 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 22 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6436966

Adenosine A3 receptor antagonists

Takeda Chemical Ind., Ltd. · Granted Tue Aug 20 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 15 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6368593

Enhanced immunogenic cell populations prepared using H2 receptor antagonists

The Regents of the University of California · Granted Tue Apr 09 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 04 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6348466

CRF receptor antagonists and methods relating thereto

Neurocrine Biosciences, Inc. · Granted Tue Feb 19 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 14 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6262064

Octahydrobenzo[f]quinoline-based receptor agonists and antagonists

State of Rhode Island and Providence Plantations · Granted Tue Jul 17 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 12 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6251903

Alkyl, azido, alkoxy, and fluoro-substituted and fused quinoxalinediones and the use there

The Regents of the University of California · Granted Tue Jun 26 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 21 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6221861

Reducing pyrophosphate deposition with calcium antagonists

The Regents of the University of California · Granted Tue Apr 24 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 19 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6211165

Methods and compositions for reducing ischemic injury of the heart by administering adenos

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Apr 03 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 29 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6211195

CRF antagonistic thiophenopyridines

Neurocrine Biosciences, Inc. · Granted Tue Apr 03 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 29 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6147075

Alkyl, azido, alkoxy and fluoro-substituted and fused quinoxalinediones and the use thereo

The Regents of the University of California · Granted Tue Nov 14 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 09 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6136781

LH-RH receptor antagonists

Takeda Chemical Industries Ltd. · Granted Tue Oct 24 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 19 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6100252

Heterocyclic compounds and their use as angiotensin antagonists

Takeda Chemical Industries Ltd. · Granted Tue Aug 08 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 03 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6080871

Sulfonamides and sulfamides as H.sub.3 receptor antagonists

The James Black Foundation Limited · Granted Tue Jun 27 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 22 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6066642

Dihydropyridine-, pyridine-, benzopyran-4-one- and triazoloquinazoline derivative, their p

The United States of America, as represented by the Department of Health and Human Services · Granted Tue May 23 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 18 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired